| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0005930 | axoneme | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q472
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005488 | binding | 1 | 2 |
| GO:0005515 | protein binding | 2 | 2 |
| GO:0045504 | dynein heavy chain binding | 3 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 201 | 203 | PF00675 | 0.318 |
| CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.334 |
| CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.329 |
| CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.371 |
| CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.357 |
| CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.319 |
| CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.289 |
| CLV_PCSK_PC1ET2_1 | 81 | 83 | PF00082 | 0.288 |
| CLV_PCSK_PC7_1 | 82 | 88 | PF00082 | 0.250 |
| CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.272 |
| CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.324 |
| CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.271 |
| CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.318 |
| CLV_Separin_Metazoa | 107 | 111 | PF03568 | 0.250 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.432 |
| DOC_MAPK_gen_1 | 170 | 178 | PF00069 | 0.333 |
| DOC_MAPK_gen_1 | 97 | 104 | PF00069 | 0.157 |
| DOC_MAPK_MEF2A_6 | 170 | 178 | PF00069 | 0.285 |
| DOC_MAPK_MEF2A_6 | 97 | 104 | PF00069 | 0.157 |
| DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.541 |
| LIG_14-3-3_CanoR_1 | 110 | 115 | PF00244 | 0.250 |
| LIG_APCC_ABBA_1 | 102 | 107 | PF00400 | 0.157 |
| LIG_APCC_ABBAyCdc20_2 | 97 | 103 | PF00400 | 0.250 |
| LIG_FHA_1 | 11 | 17 | PF00498 | 0.433 |
| LIG_FHA_2 | 111 | 117 | PF00498 | 0.320 |
| LIG_FHA_2 | 184 | 190 | PF00498 | 0.343 |
| LIG_FHA_2 | 225 | 231 | PF00498 | 0.442 |
| LIG_LIR_Gen_1 | 103 | 112 | PF02991 | 0.271 |
| LIG_LIR_Nem_3 | 103 | 108 | PF02991 | 0.298 |
| LIG_SH2_PTP2 | 101 | 104 | PF00017 | 0.157 |
| LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.250 |
| LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.338 |
| LIG_SH3_3 | 111 | 117 | PF00018 | 0.250 |
| LIG_SUMO_SIM_par_1 | 54 | 61 | PF11976 | 0.313 |
| LIG_TRAF2_1 | 113 | 116 | PF00917 | 0.309 |
| LIG_TRAF2_1 | 48 | 51 | PF00917 | 0.538 |
| LIG_UBA3_1 | 183 | 188 | PF00899 | 0.309 |
| MOD_CK1_1 | 40 | 46 | PF00069 | 0.595 |
| MOD_CK1_1 | 58 | 64 | PF00069 | 0.250 |
| MOD_CK2_1 | 110 | 116 | PF00069 | 0.324 |
| MOD_CK2_1 | 183 | 189 | PF00069 | 0.313 |
| MOD_CK2_1 | 224 | 230 | PF00069 | 0.437 |
| MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.480 |
| MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.477 |
| MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.528 |
| MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.309 |
| MOD_GSK3_1 | 224 | 231 | PF00069 | 0.520 |
| MOD_GSK3_1 | 31 | 38 | PF00069 | 0.571 |
| MOD_N-GLC_1 | 1 | 6 | PF02516 | 0.409 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.348 |
| MOD_NEK2_1 | 16 | 21 | PF00069 | 0.325 |
| MOD_NEK2_1 | 183 | 188 | PF00069 | 0.346 |
| MOD_NEK2_1 | 75 | 80 | PF00069 | 0.403 |
| MOD_PKA_2 | 228 | 234 | PF00069 | 0.458 |
| MOD_PKA_2 | 88 | 94 | PF00069 | 0.330 |
| MOD_Plk_1 | 1 | 7 | PF00069 | 0.410 |
| MOD_Plk_4 | 16 | 22 | PF00069 | 0.324 |
| MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.543 |
| MOD_SUMO_for_1 | 223 | 226 | PF00179 | 0.416 |
| MOD_SUMO_rev_2 | 207 | 212 | PF00179 | 0.467 |
| TRG_DiLeu_BaEn_4 | 195 | 201 | PF01217 | 0.313 |
| TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.324 |
| TRG_ER_diArg_1 | 200 | 202 | PF00400 | 0.351 |
| TRG_ER_diArg_1 | 86 | 89 | PF00400 | 0.334 |
| TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.330 |
| TRG_Pf-PMV_PEXEL_1 | 8 | 12 | PF00026 | 0.440 |
| TRG_Pf-PMV_PEXEL_1 | 81 | 85 | PF00026 | 0.230 |
| TRG_Pf-PMV_PEXEL_1 | 98 | 103 | PF00026 | 0.171 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4J6T9 | Bodo saltans | 39% | 98% |
| A0A0S4J9S1 | Bodo saltans | 36% | 100% |
| A0A0S4JQQ4 | Bodo saltans | 33% | 100% |
| A0A1X0NVG2 | Trypanosomatidae | 37% | 100% |
| A0A1X0NXR5 | Trypanosomatidae | 34% | 80% |
| A0A3Q8IC16 | Leishmania donovani | 36% | 100% |
| A0A3Q8IM75 | Leishmania donovani | 97% | 100% |
| A0A3R7KMX9 | Trypanosoma rangeli | 36% | 100% |
| A0A422MW64 | Trypanosoma rangeli | 40% | 66% |
| A4I0S3 | Leishmania infantum | 36% | 100% |
| A4I8Y3 | Leishmania infantum | 97% | 100% |
| C9ZRW3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 81% |
| D0A1A2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 90% |
| D0A4Y1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 66% |
| D0A753 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
| E9AIH0 | Leishmania braziliensis | 38% | 100% |
| E9AWS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
| E9B3V2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| O14645 | Homo sapiens | 37% | 96% |
| Q26630 | Strongylocentrotus purpuratus | 37% | 95% |
| Q39604 | Chlamydomonas reinhardtii | 37% | 98% |
| Q4FZV3 | Rattus norvegicus | 36% | 96% |
| Q4QAP9 | Leishmania major | 36% | 100% |
| Q4R3K5 | Macaca fascicularis | 37% | 96% |
| Q6GN86 | Xenopus laevis | 37% | 97% |
| Q8BVN8 | Mus musculus | 36% | 96% |
| Q9VGG6 | Drosophila melanogaster | 33% | 99% |
| V5B9Q0 | Trypanosoma cruzi | 36% | 68% |
| V5BR59 | Trypanosoma cruzi | 36% | 100% |